Prefilled syringes for intravitreal injection reduce preparation time.
نویسندگان
چکیده
INTRODUCTION The demand for intravitreal therapy has increased dramatically with the introduction of vascular endo-thelial growth factor inhibitors. Improved utilisation of existing resources is crucial to meeting the increased future demand. We investigated time spent preparing intravitreal injection treatment using either prefilled syringes or vials in routine clinical practice. METHODS We video-recorded preparations of intravitreal injections (n = 172) for each preparation type (ranibizumab prefilled syringe (n = 56), ranibizumab vial (n = 56) and aflibercept vial (n = 60)) in a multi-centre time and motion study. The preparation times for each step were extracted from videos and the three preparation types were compared. RESULTS Prefilled syringes eliminated several steps in the preparation process. Total preparation time was 40.3-45.1 sec. using vials, and the use of prefilled syringes saved 25.5 sec. (95% confidence interval (CI): 23.3-27.6 sec., p < 0.0001). The preparation time when aflibercept vials were used was 3.7 sec. (95% CI: 1.45-5.96 sec., p = 0.0014) longer than when ranibizumab vials were used. CONCLUSIONS Prefilled syringes for intravitreal injections reduce preparation time by eliminating preparation steps that both entail a risk of contamination and are subject to variation. The amount of time saved may enable increased utilisation of existing resources and outsourcing to non-ophthalmologists. FUNDING This study was supported by a grant from Novartis. The funders had no influence on the design of the study, analysis of the data, preparation of the manuscript or the decision to publish. TRIAL REGISTRATION not relevant.
منابع مشابه
Flexible Inspection of Prefilled Syringes
Due to an increase of chronic diseases such as diabetes and cancer, a rising number of patients require injectable drugs for self-administration. Prefilled syringes enable highly accurate dosing and decrease the exposure to potent products while, at the same time, they significantly reduce the danger of dosing errors and contribute to overall patient safety. As a result, the market for prefille...
متن کاملPrefilled Syringes for Viscous Formulations
www.ondrugdelivery.com 27 In this article, Mahesh Chaubal, PhD, Senior Director, Drug Development, R&D Medical Products, Baxter Healthcare Corporation, provides a glimpse of some of the challenges faced during the development of viscous formulations of biopharmaceutical products for injection, from a formulator’s perspective, especially when the finished product is filled in a prefilled syringe...
متن کاملExperience of unpleasant sensations in the mouth after injection of saline from prefilled syringes
BACKGROUND Nurses at The Norwegian Radium Hospital have reported that some patients notice an unpleasant smell or taste in accordance with flushing of intravenous lines with commercially available prefilled syringes. We have conducted a study in healthy volunteers to investigate the occurrence, consistency and intensity of this phenomenon. METHODS A randomised, blinded, crossover study compar...
متن کاملSPECIAL REPORT - Prefilled Syringes & Parenteral Contract Manufacturing: Improving for Flexibility & Customization
Arise in biologics and complex compounds-specifically in large-molecule drugs that require innovative injection methods-is driving the prefilled syringe market. The erosion of the blockbuster model, expiring patents, and growing competition have also increased the need for differentiation in drug delivery, while changes in demographics, particularly in the growing homecare sector, increase the ...
متن کاملSubcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience
PURPOSE This multicenter, randomized, crossover study compared preference, ease of use, acceptability, satisfaction, and safety of repeated subcutaneous (SC) self-administrations with prefilled pens and prefilled syringes delivering methotrexate (MTX), in patients with rheumatoid arthritis (RA). PATIENTS AND METHODS The study (ClinicalTrials.gov number NCT01793259) enrolled 120 patients requi...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Danish medical journal
دوره 63 4 شماره
صفحات -
تاریخ انتشار 2016